Actively Recruiting
Immune Homeostasis in Sepsis and Septic Shock
Led by Charles University, Czech Republic · Updated on 2024-08-21
200
Participants Needed
1
Research Sites
382 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Detailed description of immune response and its dynamics in sepsis and septic shock patiens by means of transcriptomics, flow-cytometry and cytokine analysis.
CONDITIONS
Official Title
Immune Homeostasis in Sepsis and Septic Shock
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of sepsis or septic shock according to SEPSIS-3 criteria
- Age 18 years or older
- Ability to provide informed consent
- Inclusion within the first 24 hours after development or diagnosis of septic shock
You will not qualify if you...
- Patient or legal representative refuses to participate in the study
- Presence of primary or secondary immunodeficiency
- Active hematological malignancy
- Active non-hematological malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical ICU, 1st Dept. of Internal Medicine, Teaching Hospital in Pilsen
Pilsen, Česká Republika, Czechia, 330 01
Actively Recruiting
Research Team
T
Thomas Karvunidis, MD, Ph.D.
CONTACT
M
Marcela Královcová, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here